Experienced in Thrombocytopenia

Yi-chang C. Liu

Kaohsiung, KHQ, TW 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Thrombocytopenia
Kaohsiung, KHQ, TW 
OverviewLocationsClinical Research

Overview

Yi-chang Liu practices in Kaohsiung, Taiwan. Liu is rated as an Experienced expert by MediFind in the treatment of Thrombocytopenia. Their top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Leukemia, and Bone Marrow Transplant.

Their clinical research consists of co-authoring 91 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Thrombocytopenia.

Locations

Kaohsiung, KHQ, Taiwan
Other Locations
Taitung, TNQ, Taiwan
TPQ, Taiwan
Tainan, TNQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase I Study of Safety, Tolerability and Pharmacokinetics of T-1301 Capsules in Subjects with Advanced Solid Tumors
A Phase I Study of Safety, Tolerability and Pharmacokinetics of T-1301 Capsules in Subjects with Advanced Solid Tumors
Enrollment Status: Recruiting
Publish Date: November 12, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer
A Phase II Randomized Study of Gemcitabine and Nab-paclitaxel in Combination With S- 1/LV (GASL) or Oxaliplatin (GAP) as First-line Treatment for Metastatic Pancreatic Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 07, 2025
Intervention Type: Drug
Study Drugs: Gemcitabine, Nab Paclitaxel, S1, Leucovorin, Oxaliplatin
Study Phase: Phase 2
View 1 Less Clinical Trial

91 Total Publications

Taiwan consensus on pulmonary chronic graft-versus-host disease: A joint statement from the Taiwan Society of Blood and Marrow Transplantation (TBMT) and Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM).
Taiwan consensus on pulmonary chronic graft-versus-host disease: A joint statement from the Taiwan Society of Blood and Marrow Transplantation (TBMT) and Taiwan Society of Pulmonary and Critical Care Medicine (TSPCCM).
Journal: British journal of haematology
Published: April 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Liu's expertise for a condition
ConditionClose
        View All 33 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile